Search research articles
Contact Us
Filters
Showing results (331-340 of 463) with videos related to
Page
of 47
Sort By:
Journal of Crohn'S & Colitis
|
February 28, 2024
Unravelling the Oral-Gut Axis: Interconnection Between Periodontitis and Inflammatory Bowel Disease, Current Challenges, and Future Perspective
Himanshi Tanwar, Jeba Mercy Gnanasekaran, Devon Allison, et al.
Gastroenterology
|
April 17, 2012
Abatacept for Crohn's disease and ulcerative colitis
William J Sandborn, Jean-Frederic Colombel, Bruce E Sands, et al.
Journal of Clinical Medicine
|
December 28, 2019
Safety of P28GST, a Protein Derived from a Schistosome Helminth Parasite, in Patients with Crohn's Disease: A Pilot Study (ACROHNEM)
Monique Capron, Laurent Béghin, Céline Leclercq, et al.
Arxiv
|
August 30, 2023
Unraveling the Link between Periodontitis and Inflammatory Bowel Disease: Challenges and Outlook
Himanshi Tanwar, Jeba Mercy Gnanasekaran, Devon Allison, et al.
Gut
|
July 10, 2019
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
Remo Panaccione, Jean-Frederic Colombel, Simon P L Travis, et al.
Gut Microbes
|
February 7, 2025
Alterations in mucosa branched <i>N</i>-glycans lead to dysbiosis and downregulation of ILC3: a key driver of intestinal inflammation
Cláudia S Rodrigues, Joana Gaifem, Márcia S Pereira, et al.
The American Journal of Gastroenterology
|
December 1, 2007
Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction
Peggy Vandewalle-El Khoury, Jean-Frederic Colombel, Sofie Joossens, et al.
Alimentary Pharmacology & Therapeutics
|
July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease
Stefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
Inflammatory Bowel Diseases
|
February 28, 2020
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study
Walter Reinisch, Remo Panaccione, Peter Bossuyt, et al.
Journal of Crohn'S & Colitis
|
January 3, 2018
Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives
Nanne K H de Boer, Laurent Peyrin-Biroulet, Bindia Jharap, et al.
Page
of 47
Search research articles
Search
Showing results (331-340 of 463) with videos related to
Sort By:
Page
of 47
Journal of Crohn'S & Colitis
|
February 28, 2024
Unravelling the Oral-Gut Axis: Interconnection Between Periodontitis and Inflammatory Bowel Disease, Current Challenges, and Future Perspective
Himanshi Tanwar, Jeba Mercy Gnanasekaran, Devon Allison, et al.
Gastroenterology
|
April 17, 2012
Abatacept for Crohn's disease and ulcerative colitis
William J Sandborn, Jean-Frederic Colombel, Bruce E Sands, et al.
Journal of Clinical Medicine
|
December 28, 2019
Safety of P28GST, a Protein Derived from a Schistosome Helminth Parasite, in Patients with Crohn's Disease: A Pilot Study (ACROHNEM)
Monique Capron, Laurent Béghin, Céline Leclercq, et al.
Arxiv
|
August 30, 2023
Unraveling the Link between Periodontitis and Inflammatory Bowel Disease: Challenges and Outlook
Himanshi Tanwar, Jeba Mercy Gnanasekaran, Devon Allison, et al.
Gut
|
July 10, 2019
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
Remo Panaccione, Jean-Frederic Colombel, Simon P L Travis, et al.
Gut Microbes
|
February 7, 2025
Alterations in mucosa branched <i>N</i>-glycans lead to dysbiosis and downregulation of ILC3: a key driver of intestinal inflammation
Cláudia S Rodrigues, Joana Gaifem, Márcia S Pereira, et al.
The American Journal of Gastroenterology
|
December 1, 2007
Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction
Peggy Vandewalle-El Khoury, Jean-Frederic Colombel, Sofie Joossens, et al.
Alimentary Pharmacology & Therapeutics
|
July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease
Stefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
Inflammatory Bowel Diseases
|
February 28, 2020
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study
Walter Reinisch, Remo Panaccione, Peter Bossuyt, et al.
Journal of Crohn'S & Colitis
|
January 3, 2018
Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives
Nanne K H de Boer, Laurent Peyrin-Biroulet, Bindia Jharap, et al.
Page
of 47